Myasthenia gravis: Diagnostic and management dilemmas

Current Opinion in Neurology

Volumn 14, Issue 5, 2001, Pages 583-589

  Palace, Jackie ^a   Vincent, Angela ^b   Beeson, David ^b  

^a RADCLIFFE INFIRMARY   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; AZATHIOPRINE; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ANTIBODY; CORTICOSTEROID; CYCLOSPORIN; MUSCLE ANTIBODY; PROTEIN TYROSINE KINASE;

AUTOIMMUNE DISEASE; DIAGNOSTIC TEST; ELECTROMYOGRAPHY; MYASTHENIA; MYASTHENIA GRAVIS; PLASMAPHERESIS; PRESYNAPTIC NERVE; REVIEW; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; THYMECTOMY;

HUMANS; MYASTHENIA GRAVIS; RECEPTORS, CHOLINERGIC;

EID: 0034799101     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200110000-00006     Document Type: Review

References (38)

1. Myasthenia gravis and Lambert-Eaton myasthenic syndrome
2. Myasthenia gravis without acetylcholine-receptor antibody: A distinct disease entity
3. Seronegative myasthenia gravis: A plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM
4. Modulation of acetylcholine receptor expression in seronegative myasthenia gravis
5. IgC from 'seronegative' myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor
6. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies
7. Formation of the neuromuscular junction. Agrin and its unusual receptors
8. The complication rate of edrophonium testing for suspected myasthenia gravis
9. SFEMG in ocular myasthenia gravis diagnosis
10. Stimulated single fiber EMG of the frontalis muscle in the diagnosis of ocular myasthenia
11. A cold test for myasthenia gravis
12. An ice test for the diagnosis of myasthenia gravis
13. The ice test versus the rest test in myasthenia gravis
14. Extraocular muscle responses to orbital cooling (ice test) for ocular myasthenia gravis diagnosis
15. Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia
16. Muscle autoantibodies in subgroups of myasthenia gravis patients
17. Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis. A study of IgG subclasses and clinical correlations
18. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies
19. Congenital myasthenic syndromes
20. Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans
21. Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme
22. The spectrum of mutations causing end-plate acetylcholinesterase deficiency
23. Mutation in the human acetylcholinesterase-associated collagen gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (Type Ic)
24. Practice parameter: Thymectomy for autoimmune myasthenia gravis (an evidence, based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
25. Effects of preoperative duration of symptoms on patients with myasthenia gravis
26. Thoracoscopic thymectomy in juvenile myasthenia gravis
27. Thoracoscopic thymectomy in autoimmune myasthesia: Results of left-sided approach
28. Videothoracoscopic approach to primary mediastinal pathology
29. Pulmonary function after thoracoscopic thymectomy versus median sternotomy for myasthenia gravis
30. Results of video-assisted thymectomy in patients with myasthenia gravis
31. Comparison between double-filtration plasmapheresis and immunoadsorption plasmapheresis in the treatment of patients with myasthenia gravis
32. The six year experience of plasmapheresis in patients with myasthenia gravis
33. Mycophenolate mofetil for myasthenia gravis: An open-label pilot study
34. Retrospective analysis of the use of cyclosporine in myasthenia gravis
35. Validity and reliability of two muscle strength scores commonly used as endpoints in assessing treatment of myasthenia gravis
36. Maximal bite force and surface EMG in patients with myasthenia gravis
37. Tongue force in patients with myasthenia gravis
38. Myasthenia gravis: Recommendations for clinical research standards